抗体依赖性细胞介导的细胞毒性
免疫监视
免疫疗法
单克隆抗体
自然杀伤细胞
癌症免疫疗法
免疫学
先天免疫系统
生物
效应器
癌症研究
抗体
细胞毒性
免疫系统
生物化学
体外
作者
Joshua K M Wong,Riccardo Dolcetti,Handoo Rhee,Fiona Simpson,Fernando Souza‐Fonseca‐Guimaraes
标识
DOI:10.1016/j.trecan.2022.10.009
摘要
Enhancing natural killer (NK) cell-based innate immunity has become a promising strategy for immunotherapy against hard-to-cure solid cancers. Monoclonal antibody (mAb) therapy has been used to activate NK-cell-mediated antibody-dependent cellular cytotoxicity (ADCC) towards solid cancers. Cancer cells, however, can subvert immunosurveillance using multiple immunosuppressive mechanisms, which may hamper NK cell ADCC. Mechanisms to safely enhance ADCC by NK cells, such as utilizing temporary inhibition of receptor endocytosis to increase antibody presentation from target to effector cells can now be used to enhance NK-cell-mediated ADCC against solid tumors. This review summarizes and discusses the recent advances in the field and highlights current and potential future use of immunotherapies to maximize the therapeutic efficacy of innate anticancer immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI